Parkinson's disease

Active Ingredient: Piribedil

Indication for Piribedil

Population group: only adults (18 years old or older)
Therapeutic intent: Curative procedure

For this indication, competent medicine agencies globally authorize below treatments:

150-250 mg daily

For:

Dosage regimens

Oral, between 150 milligrams piribedil and 250 milligrams piribedil, divided daily to meals.

Detailed description

Treatment of Parkinson’s disease as monotherapy: 150 mg to 250 mg per day.

These doses must be attained gradually.

Dosage considerations

To be taken with a half-glass of water, without chewing, at the end of meals.

Active ingredient

Piribedil

Piribedil is a dopaminergic agonist (stimulates dopamine receptors and the cerebral dopaminergic pathways).

Read more about Piribedil

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.